Shirley Ryan AbilityLab

Quick facts

Marketed products

• Gralise · Other
• Hydromorphone ER · Pain Management
  Hydromorphone ER is an opioid agonist that binds to mu-opioid receptors in the central nervous system to produce analgesia and pain relief.

Phase 2 pipeline

• 5-Azacitidine · Oncology
  Inhibits DNA methyltransferase

Phase 1 pipeline

• Botulinum Toxin Type A - OnabotulinumtoxinA

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Shirley Ryan AbilityLab portfolio CI brief
• Shirley Ryan AbilityLab pipeline updates RSS